- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02143700
Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients (COPD)
Clinical Profile and Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Chronic obstructive pulmonary disease is a pathology with a systemic impact with a progressive evolution that is characterized by the presence of chronic airflow obstruction.
Patients with COPD may have problems with cognitive functioning, either globally or in single cognitive domains, such as information processing, attention and concentration, memory, executive functioning and self-regulation.
Several studies have determined the prevalence of cognitive impairment in COPD compared to healthy control subjects, reaching very high levels, 36% of COPD patients with mild cognitive impairment compared with 12 % non- COPD subjects.
Studietype
Inschrijving (Verwacht)
Contacten en locaties
Studie Locaties
-
-
-
Granada, Spanje, 18071
- Werving
- Department of Physical Therapy
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Clinical diagnosis of chronic obstructive pulmonary disease with exacerbation or stable.
- Signed written consent.
- Medical approval for inclusion
Exclusion Criteria:
- Heart disease.
- Neurological patients.
- Severe cognitive impairment in order not to complete the assessment.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Stable and exacerbated patients
Patients diagnosed of chronic obstructive pulmonary disease in a stable or exacerbated situation.
Cognitive assessment of these patients will be performed.
|
Patients are going to be assessed regarding the outcome measures
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Cognitive impairment
Tijdsspanne: Baseline
|
The cognitive impairment will be measured using the Montreal Cognitive Assessment.
The Montreal Cognitive Assessment is a test designed as a rapid screening instrument for mild cognitive dysfunction.
It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation.
|
Baseline
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Sleep quality
Tijdsspanne: Baseline
|
Participants are going to complete the Pittsburgh Quality of Sleep Index.
This is a self-rating questionnaire with seven subscores that result in a global score between 0 and 21.
|
Baseline
|
|
Activity monitoring
Tijdsspanne: Baseline
|
The accelerometer Armband is going to be used for activity monitoring.
It measures the intensity of the activity during 12 hours.
|
Baseline
|
|
Nutritional state
Tijdsspanne: Baseline
|
Mini Nutritional Assessment has been designed and validated to provide a single, rapid assessment of nutritional status in elderly patients in outpatient clinics, hospitals, and nursing homes.
It is composed of simple measurements and brief questions that can be completed in about 10 min
|
Baseline
|
|
Quality of life
Tijdsspanne: Baseline
|
Quality of life associated with health is going to be measured with two questionnaires: the EuroQol-5 questionnaire and the Health Questionnaire St. George
|
Baseline
|
|
Cough
Tijdsspanne: Baseline
|
The Leicester Cough Questionnaire-acute is a validated cough-related health status questionnaire designed for patients with chronic cough.
|
Baseline
|
|
Comorbidities
Tijdsspanne: Baseline
|
Comorbidities are going to be measured with the Charlson comorbidity index.
The Charlson comorbidity index predicts the ten-year mortality for a patient who may have a range of comorbid conditions, such as heart disease, AIDS, or cancer (a total of 22 conditions).
Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one.
|
Baseline
|
|
Anxiety and depression
Tijdsspanne: Baseline
|
Patients are going to completed the Hospital Anxiety and Depression Scale composed of statements relevant to either generalized anxiety or depression.
|
Baseline
|
|
Cognitive flexibility
Tijdsspanne: Baseline
|
The cognitive flexibility of patients is measured using the Trial Making Test.
This test explores visual-conceptual and visual-motor tracking, and it is a frequently used neuropsychological test.
|
Baseline
|
|
Forced vital capacity
Tijdsspanne: Baseline
|
Forced vital capacity is going to be measured with a spirometer as recommended by the American Thoracic Society
|
Baseline
|
|
Forced expiratory volume in the first second
Tijdsspanne: Baseline
|
Forced expiratory volume in the first second is going to be measured with a spirometer as recommended by the American Thoracic Society
|
Baseline
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- DF0051UG
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .